Inventiva announces the nomination of Andre Turenne as Director
Frédéric Cren, Chairman, Chief Executive Officer, and cofounder of Inventiva: “We are extremely pleased that our Board of Directors has proposed the appointment of Andre.
- Frédéric Cren, Chairman, Chief Executive Officer, and cofounder of Inventiva: “We are extremely pleased that our Board of Directors has proposed the appointment of Andre.
- We look forward to welcoming Andre as the newest member of our Board of Directors.”
Mr. Turenne has more than 20 years of global experience in the pharmaceutical industry. - Prior to joining Matchpoint, Mr. Turenne served as President and Chief Executive Officer of Voyager Therapeutics.
- Andre Turenne, non-executive director nominee: “I am delighted to have the opportunity to join the Board of Directors of Inventiva, which is at a pivotal stage in its clinical program in NASH.